Meng Li, Executive Medical Director, Oncology Clinical Development at AbbVie, shared on LinkedIn:
”I’m excited to share that I am starting a new career chapter as Executive Medical Director, Oncology Development at AbbVie!
During my time at Pfizer, I was privileged to serve as Global Development Lead and Global Clinical Lead for multiple oncology assets across early- and late-stage clinical development. I’m proud of the work we advanced, the teams I had the opportunity to learn from and lead, and the shared commitment to bringing meaningful therapies to patients.
I am also deeply grateful for my mentors, colleagues, friends, and collaborators across industry and academia who have shaped my journey. Witnessing the lightspeed, dedication, and global collaboration behind COVID-19 vaccines and therapies reinforced what science can achieve when urgency, innovation, resources, and purpose come together.
I am thrilled to join AbbVie, a company whose work has made a meaningful difference in people’s health and daily lives. I look forward to learning from talented new colleagues, contributing to a culture of compassion and relentless innovation, and helping build a strong oncology development organization dedicated to advancing novel therapies for people living with cancer.”
Other articles about AbbVie on OncoDaily.